{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T17:26:33Z","timestamp":1783531593484,"version":"3.55.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,27]],"date-time":"2022-05-27T00:00:00Z","timestamp":1653609600000},"content-version":"vor","delay-in-days":1941,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","fertstert.org","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Fertility and Sterility"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1016\/j.fertnstert.2016.10.031","type":"journal-article","created":{"date-parts":[[2016,11,22]],"date-time":"2016-11-22T18:45:41Z","timestamp":1479840341000},"page":"430-438.e3","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":112,"title":["Supplementation with progestogens in the first trimester of pregnancy to prevent miscarriage in women with unexplained recurrent miscarriage: a systematic review and meta-analysis of randomized, controlled trials"],"prefix":"10.1016","volume":"107","author":[{"given":"Gabriele","family":"Saccone","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corina","family":"Schoen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason M.","family":"Franasiak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"Richard T.","family":"Scott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"Berghella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.fertnstert.2016.10.031_bib1","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/S0140-6736(06)69204-0","article-title":"Recurrent miscarriage","volume":"368","author":"Rai","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.fertnstert.2016.10.031_bib2","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/j.fertnstert.2012.06.048","article-title":"Evaluation and treatment for recurrent pregnancy loss: a committee opinion","volume":"98","year":"2012","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2016.10.031_bib3","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1093\/humupd\/dmg043","article-title":"A comparison of placental development and endocrine functions between the human and mouse model","volume":"9","author":"Malassin\u00e9","year":"2003","journal-title":"Hum Reprod Update"},{"issue":"Suppl 3","key":"10.1016\/j.fertnstert.2016.10.031_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/humrep\/15.suppl_3.1","article-title":"A functional model for progestogen-induced breakthrough bleeding","volume":"15","author":"Hickey","year":"2000","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2016.10.031_bib5","first-page":"CD004947","article-title":"Prenatal administration of progesterone for preventing preterm birth in women considered to be at risk of preterm birth","author":"Dodd","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.fertnstert.2016.10.031_bib6","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.ajog.2012.03.010","article-title":"Progesterone and preterm birth prevention: translating clinical trials data into clinical practice","volume":"206","year":"2012","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2016.10.031_bib7","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1056\/NEJMoa035140","article-title":"National Institute of Child Health and Human Development Maternal-Fetal Medicien Units Network. Prevention of recurrent preterm delivery by 17 alpha-hydroxyprogesterone caproate","volume":"348","author":"Meis","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.fertnstert.2016.10.031_bib8","doi-asserted-by":"crossref","first-page":"124.e1","DOI":"10.1016\/j.ajog.2011.12.003","article-title":"Vaginal progesterone in women with an asymptomatic sonographic short cervix in the midtrimester decreases preterm delivery and neonatal morbidity: a systematic review and metaanalysis of individual patient data","volume":"2","author":"Romero","year":"2012","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2016.10.031_bib9","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1111\/j.1471-0528.1965.tb01540.x","article-title":"Double blind controlled trial of 6-methyl-17-acetoxyprogesterone in threatened abortion","volume":"72","author":"Moller","year":"1965","journal-title":"J Obstet Gynecol Br Comm"},{"key":"10.1016\/j.fertnstert.2016.10.031_bib10","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.ajog.2015.03.031","article-title":"Vaginal progesterone for maintenance tocolysis: a systematic review and metaanalysis of randomized trials","volume":"213","author":"Suhag","year":"2015","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2016.10.031_bib11","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.ajog.2015.01.054","article-title":"17-alpha-hydroxyprogesterone caproate for maintenance tocolysis: a systematic review and metaanalysis of randomized trials","volume":"213","author":"Saccone","year":"2015","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2016.10.031_bib12","first-page":"CD003511","article-title":"Progestogen for preventing miscarriage","author":"Haas","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.fertnstert.2016.10.031_bib13","unstructured":"Higgins JPT, Green S, eds. Cochrane handbook for systematic reviews of interventions, version 5.1.0 (update March 2011). The Cochrane Collaboration 2011. Available at: www.cochrane-handbook.org. Accessed December 20,\u00a02015."},{"key":"10.1016\/j.fertnstert.2016.10.031_bib14","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/j.jclinepi.2009.06.005","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"62","author":"Moher","year":"2009","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.fertnstert.2016.10.031_bib15","first-page":"353","article-title":"Is hormonal therapy still justified in imminent abortion?","volume":"184","author":"Berle","year":"1980","journal-title":"Z Geburtshilfe Perinatol"},{"key":"10.1016\/j.fertnstert.2016.10.031_bib16","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/S0301-2115(01)00418-3","article-title":"A randomised trial of progesterone prophylaxis after midtrimester amniocentisis","volume":"100","author":"Corrado","year":"2002","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.fertnstert.2016.10.031_bib17","first-page":"26","article-title":"Double-blind controlled trial of progesterone substitution in threatened abortion","volume":"8","author":"Gerhard","year":"1987","journal-title":"Biol Res Pregnancy"},{"key":"10.1016\/j.fertnstert.2016.10.031_bib18","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1111\/j.1471-0528.1965.tb01533.x","article-title":"Hormones in recurrent abortion","volume":"72","author":"Klopper","year":"1965","journal-title":"J Obstet Gynecol Br Comm"},{"key":"10.1016\/j.fertnstert.2016.10.031_bib19","first-page":"394","article-title":"Cervical mucus, vaginal cytology and steroid excretion in recurrent abortion","volume":"40","author":"MacDonald","year":"1972","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2016.10.031_bib20","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1093\/humrep\/17.2.357","article-title":"Progesterone supplementation during early gestations after IVF or ICSI has no effect on the delivery rates: a randomized controlled trial","volume":"17","author":"Nyboe Anderson","year":"2002","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2016.10.031_bib21","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1111\/j.1471-0528.1988.tb12797.x","article-title":"Endocrine effects of 17 alpha-hydroxyprogesterone caproate during early pregnancy: a double-blind clinical trial","volume":"95","author":"Reijnders","year":"1988","journal-title":"Br J Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2016.10.031_bib22","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1136\/bmj.1.5326.292","article-title":"Double-blind study of effect of 17-hydroxyprogesterone caproate on abortion rate","volume":"1","author":"Shearman","year":"1963","journal-title":"Br Med J"},{"key":"10.1016\/j.fertnstert.2016.10.031_bib23","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1016\/S0140-6736(80)92496-4","article-title":"Progestogens in threatened abortion","volume":"2","author":"Tognoni","year":"1980","journal-title":"Lancet"},{"key":"10.1016\/j.fertnstert.2016.10.031_bib24","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1056\/NEJMoa1504927","article-title":"A randomized trial of progesterone in women with recurrent miscarriages","volume":"373","author":"Coomarasamy","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.fertnstert.2016.10.031_bib25","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.jsbmb.2005.08.007","article-title":"Dydrogesterone in the reduction of recurrent spontaneous abortion","volume":"97","author":"El-Zibdeh","year":"2005","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1016\/j.fertnstert.2016.10.031_bib26","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1001\/jama.1964.03060330031008","article-title":"Double-blind trial of a progestin in habitual abortion","volume":"188","author":"Goldzieher","year":"1964","journal-title":"JAMA"},{"key":"10.1016\/j.fertnstert.2016.10.031_bib27","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1016\/j.fertnstert.2014.07.1251","article-title":"Oral dydrogesterone treatment during early pregnancy to prevent recurrent pregnancy loss and its role in modulation of cytokine production: a double-blind, randomized, parallel, placebo-controlled trial","volume":"102","author":"Kumar","year":"2014","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2016.10.031_bib28","first-page":"30","article-title":"Habitual abortion. A controlled clinical study of progestational therapy","volume":"72","author":"Le Vine","year":"1964","journal-title":"West J Med"},{"key":"10.1016\/j.fertnstert.2016.10.031_bib29","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1136\/bmj.1.4819.1073","article-title":"Progesterone implantation in habitual abortion","volume":"1","author":"Swyer","year":"1953","journal-title":"Br Med J"},{"key":"10.1016\/j.fertnstert.2016.10.031_bib30","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.ajog.2015.10.934","article-title":"Prevention of preterm birth with vaginal progesterone or 17-alpha-hydroxyprogesterone caproate: a critical examination of efficacy and safety","volume":"214","author":"O'Brien","year":"2016","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2016.10.031_bib31","first-page":"1","article-title":"Combined progesterone (IM + V) versus vaginal progesterone for luteal support in cleavage-stage embryo transfer cycles of good prognosis patients","volume":"6","author":"Pabuccu","year":"2016","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.fertnstert.2016.10.031_bib32","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.fertnstert.2014.01.018","article-title":"Luteal phase support for frozen embryo transfer cycles: intramuscular or vaginal progesterone?","volume":"101","author":"Casper","year":"2014","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2016.10.031_bib33","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/s00404-012-2340-4","article-title":"Use of progestogens in pregnant and infertile patient","volume":"286","author":"Ozlu","year":"2012","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.fertnstert.2016.10.031_bib34","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1111\/j.1365-2265.2012.04464.x","article-title":"An integrated view on the luteal phase: diagnosis and treatment in subgertility","volume":"77","author":"Sonntag","year":"2012","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.fertnstert.2016.10.031_bib35","doi-asserted-by":"crossref","first-page":"44","DOI":"10.4103\/2230-8210.107834","article-title":"Luteal insufficiency in first trimester","volume":"17","author":"Shah","year":"2013","journal-title":"Indian J Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2016.10.031_bib36","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.ajog.2013.04.027","article-title":"Progesterone is not the same as 17\u03b1-hydroxyprogesterone caproate: implications for obstetrical practice","volume":"208","author":"Romero","year":"2013","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2016.10.031_bib37","first-page":"CD006770","article-title":"Progestational agents for treating threatened or established preterm labour","author":"Su","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.fertnstert.2016.10.031_bib38","first-page":"CD002126","article-title":"Progesterone or progestogen-releasing intrauterine systems for heavy menstrual bleeding","author":"Lethaby","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.fertnstert.2016.10.031_bib39","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/s40273-014-0133-2","article-title":"Cost and cost effectiveness of vaginal progesterone gel in reducing preterm birth: an economic analysis of the PREGNANT trial","volume":"32","author":"Pizzi","year":"2014","journal-title":"Pharmaeconomics"},{"key":"10.1016\/j.fertnstert.2016.10.031_bib40","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1097\/AOG.0b013e31821c2d75","article-title":"Unjustified increase in cost of care resulting from US Food and Drug Administration approval of Makena (17-alfa-hydroxyprogesterone caproate)","volume":"117","author":"Cohen","year":"2011","journal-title":"Obstet Gynecol"}],"container-title":["Fertility and Sterility"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028216629540?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028216629540?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,10,23]],"date-time":"2022-10-23T06:45:34Z","timestamp":1666507534000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0015028216629540"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2]]},"references-count":40,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,2]]}},"alternative-id":["S0015028216629540"],"URL":"https:\/\/doi.org\/10.1016\/j.fertnstert.2016.10.031","relation":{},"ISSN":["0015-0282"],"issn-type":[{"value":"0015-0282","type":"print"}],"subject":[],"published":{"date-parts":[[2017,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Supplementation with progestogens in the first trimester of pregnancy to prevent miscarriage in women with unexplained recurrent miscarriage: a systematic review and meta-analysis of randomized, controlled trials","name":"articletitle","label":"Article Title"},{"value":"Fertility and Sterility","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.fertnstert.2016.10.031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a92016 American Society for Reproductive Medicine, Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}